Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 31, 2017 08:00 ET | Source: SAMUMED

Samumed Initiates Phase 1b Trial of SM04755 for Treatment of Psoriasis

- Top-line data expected by Q2 2018 - SAN DIEGO, Oct. 31, 2017 (GLOBE NEWSWIRE) -- Samumed, LLC, today announces the enrollment of the first psoriasis patient in its Phase 1b trial of SM04755, a...
October 24, 2017 08:00 ET | Source: SAMUMED

Samumed Announces 52-week Phase 2 Osteoarthritis Data Supporting the Potential of SM04690 as a Disease Modifying Drug

- SM04690 exhibited clinically meaningful and significant improvements in pain, function, and joint space width in unilateral symptomatic osteoarthritis patients - - Samumed will be presenting data...